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Abstract
Concerns over interactions between analgesics and experimental outcomes are a major
reason for withholding opioids from rats undergoing surgical procedures. Only a fraction of
morphine injected intravenously reaches receptors responsible for analgesia in the central
nervous system. Intrathecal administration of morphine may represent a way to provide
rats with analgesia while minimizing the amount of morphine injected. This study aimed to
assess whether morphine injected intrathecally via direct lumbar puncture provides suffi-
cient analgesia to rats exposed to acute surgical pain (caudal laparotomy).In an initial
blinded, randomised study, pain-free rats received morphine subcutaneously (MSC, 3mg.
kg-1, N = 6), intrathecally (MIT, 0.2mg.kg-1, N = 6); NaCl subcutaneously (NSC, N = 6) or
intrathecally (NIT, N = 6). Previously validated pain behaviours, activity and Rat Grimace
Scale (RGS) scores were recorded at baseline, 1, 2, 4 and 8h post-injection. Morphine-
treated rats had similar behaviours to NaCl rats, but their RGS scores were significantly dif-
ferent over time and between treatments. In a second blinded study, rats (N = 28) were ran-
domly allocated to one of the following four treatments (N = 7): MSC, 3mg.kg-1, surgery;
MIT, 0.2mg.kg-1, surgery; NIT, surgery; NSC, sham surgery. Composite Pain Behaviours
(CPB) and RGS were recorded as previously. CPB in MIT and MSC groups were not signifi-
cantly different to NSC group. MSC and MIT rats displayed significantly lower RGS scores
than NIT rats at 1 and 8h postoperatively. RGS scores for MIT and MSC rats were not sig-
nificantly different at 1, 2, and 8h postoperatively. Intraclass correlation value amongst
operators involved in RGS scoring (N = 9) was 0.913 for total RGS score. Intrathecal mor-
phine was mostly indistinguishable from its subcutaneous counterpart, providing pain relief
lasting up to 8 hours in a rat model of surgical pain. Further studies are warranted to clarify
the relevance of the rat grimace scale for assessing pain in rats that have received opioid
analgesics.
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Introduction
Rodents remain the most commonly used animals for fundamental science and translational
medicine [1]. Public perception and acceptance of animal models for biomedical research relies
on the respect of fundamental ethical rules, such as the systematic implementation of the 3Rs:
replacement, reduction and refinement [2–5]. In particular, refinement, which aims to reduce
to a minimum any pain or distress caused by research procedures [6] can be applied to any sur-
gical procedures by providing effective analgesia. The need to adopt this approach is a require-
ment of the European Directive EU 2010/63/EU (Article 14) [4]. Whilst the vast majority of
rodent surgical research procedures are performed under anaesthesia, surveys indicate that the
use of perioperative analgesics remains low; e.g. in less than 25% of rats undergoing surgery
[7–9]. The main reported reasons for this are concerns over interactions with results of studies
or potential negative side-effects from the analgesic themselves, or simply that there was no
perceived need for using pain relief as a consequence of an inability to effectively recognise
pain [7,8,10].
Morphine, widely used in humans since the early years of the 19th century, is a full agonist
of the mu-opioid receptor that is well absorbed under clinically used routes of administration
[11–13]. It is commonly used for the prevention and treatment of severe acute and chronic
pain in both humans and animals [14,15]. Clinically relevant side effects of morphine in pain-
ful rodents are negligible when administered at appropriate doses for a short duration [14].
However, pica has been cited as a reason for withholdingmorphine and other opioids such as
buprenorphine in rats [16,17]. The incidence of pica-type behaviour depends on several factors
such as dose, frequency of opioid administration, strain of rat and type of bedding [17,18]. In
rodents, respiratory depression, another commonly quoted side effect following opioid use
appears to have little clinical significance in rodents [19,20]. Concerns related to the effects of
opioids on various physiological systems may be relevant in some specific research areas; for
example the immunomodulatory effects of morphine. Morphine use could trigger a series of
effects, such as pro-inflammatory variation in the nervous system [21] and altered tumour
growth profiles [22,23]. Many of these effects can be minimised by reduction of the dose of
morphine administered [23]. For example, following intravenous administration of morphine
in humans, only about 0.1% of the total drug administered is present in the central nervous sys-
tem (CNS) at the time of peak plasma concentration [24]. Reasons for the relative poor pene-
tration of morphine into the CNS include its relatively poor lipid solubility compared to other
opioids and rapid conjugation (metabolism) with glucuronic acid. If the same is true in ani-
mals, then use of alternative routes of administration could enable effective analgesia to be pro-
vided with lower total doses of morphine. Morphine is commonly administered neuraxially
(epidural or intrathecal routes) in non-rodent species [25,26]. In humans, the ratio of potencies
between intrathecal (IT) and intravenous (IV) routes of administration is 1/200 [27]; i.e. equi-
potent analgesic effects can be achieved using a dose that is 200 times less if the IT route is
chosen.
Techniques for intrathecal injection in rats have been described and although technically
more challenging than parenteral routes of injection, could provide a practical means of estab-
lishing effective analgesia with a much reduced dose of morphine [28–31]. Intrathecal mor-
phine was shown to alleviate pain in rats using nociceptive assays in the Brennan model of
post-operative pain [32], and to restore exploratory behaviour post sub-costal laparotomy [33]
and rearing as well as ambulation in a rat model of knee surgery [34]. Intrathecal injection in
rats is also widely used to test therapeutic targets [35].
Refinement of research procedures involving animals partly relies on effective ways to pre-
vent and alleviate pain; which requires effective and reliable methods to detect and quantify
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pain. Considerable progress has beenmade in developing such techniques in rats, providing
assessment methods that are more relevant to the assessment of post-operative pain than basic
nociceptive tests. Current widely used approaches measure a range of pain specific behaviours
and use these to construct scales for assessing pain (e.g. the Composite Pain Scale) [36]. These
scales can be used effectively, but can be influenced by non-specific behavioural effects of opi-
oids such as morphine [37,38]. Facial expressions can also be used to assess pain [39]. Grimace
scales have been developed for rodents [40–42], and have been used to refine experimental
models [43,44] or assess the efficacy of common analgesic drugs [45,46], However, such scales
have been suggested to be influenced by non-specific behavioural effects of opioids [41] and
further validation must be carried out to determine if they are a suitable method of pain assess-
ment followingmorphine administration.
The aims of this study were to assess if intrathecal morphine could provide sufficient analge-
sia to prevent pain in rats undergoing caudal laparotomy, as assessed by analysis of behavioural
changes and the rat grimace scale.We hypothesised that a lower dose of morphine, adminis-
tered pre-emptively by the intrathecal route would have similar analgesic properties to a rou-
tine dose injected SC.We also tested the hypothesis that this lower dose of morphine would
have fewer non-specific behavioural effects than morphine administered at higher doses by the
SC route.
Material and Methods
Ethical statement
All procedures were carried out under Home Office approved project and personal licenses
(PPL 60/4431), compliant with the Animals (Scientific Procedures) Act 1986, EU directive
(2010/63) and the AnimalWelfare, Ethics ReviewBody at Newcastle University (AWERB).
Animals and husbandry
Fifty-two femaleWistar rats (Charles River Laboratories, Kent, UK) were used in this study
(270±14.7g; 61±3 days old). All animals were housed in randomly allocated groups of 3 to 5
rats per cage (RC2 cages, North Kent Plastics Company), provided with environmental enrich-
ment (cardboard tubes, Datesand, Manchester, UK), sawdust substrate (Aspen 4HK, UK) and
nesting material (Sizzle nest, LBS technology, Surrey, UK). Food (RM3, SDS Ltd, Witham, UK)
and tap water were provided ad libitum. Room temperature was 21±2°C, humidity was 55
±10%, with a 12h light cycle (7am-7pm). All rats were allowed to acclimatize for 7 days before
starting the experiment, during which time the rats were habituated to the laboratory and
researchers. The animals were free from any common pathogens in accordance with the
FELASA health monitoring recommendations.
Study Design
This study comprised of two phases. The 1st phase was designed to assess the effect of mor-
phine, delivered subcutaneously (SC) or intrathecally (IT), on behaviour and facial expressions
in pain free rats. The second phase was designed to assess similar effects on rats following
abdominal surgery. While each phase was performed and analysed separately; the study design
and the method of collecting data were identical in each phase. The study design is therefore
only describedonce. Two main operators were involved in this study: the anaesthetist injecting
the rats (AT- blinded to the nature of the injection) and the surgeon (PAF, 2nd phase only,
blinded to the nature and the site of injection). Three other operators assisted with the
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recording of behaviour and facial expression data. All 3 operators were blinded to the nature
and site of the injection received by the rats (NaCl vs. morphine).
Treatment groups
Twenty-four and twenty-eight rats were randomly allocated to one of 4 treatment groups in
phase 1 and 2 of the study, respectively. All treatment groups are described in Tables 1 and 2.
Random allocated was carried out using an online random number generator (www.random.
org). Treatment groups 1.1 to 1.4 (1st phase) were control groups designed to assess the possi-
ble effect of morphine (SC and IT) on behaviour and facial expression of pain-free rats. Treat-
ment groups 2.1 to 2.4 (2nd phase) were designed to assess the analgesic action of morphine
(SC and IT) on acute surgical pain in rats. The morphine used (treatment groups 1.3, 1.4, 2.3,
2.4) was sterile and free of preservative (Morphine sulphate, 1mg.ml-1, South DevonHealth-
care, Paignton, UK). The NaCl solution used (treatments groups 1.1, 1.2, 2.1, 2.2) was normal
(0.9% w/v) and sterile (Braun, Melsungen, Germany). The dose of morphine selected for SC
administration is commonly used in rats post-operative analgesia [14,47,48]. The dose for
intrathecal injection (0.2 mg.kg-1) was selected from previous pilot studies (non-published
data) and represents the highest dose and volume (average 54 μg and 54 μl) of morphine that
can be administered without causing significant side effects (i.e. respiratory depression).
Anaesthesia
All treatments were carried under general anaesthesia, between 08.00am and 12.00noon.
Anaesthesia was induced in a 7L Plexiglas induction chamber with sevoflurane (inspired frac-
tion of sevoflurane (FiSevo) = 8%, Abbott, Maidenhead, UK) delivered in 4 l.min-1 O2. After
loss of consciousness (assessed by loss of the righting reflex), the rats were transferred from the
chamber and anaesthesia maintained using a rodent-size facemask (VetTech Solutions Ltd,
Cheshire, UK) with sevoflurane (FiSevo = 2.4% delivered in 1.5l.min-1 O2). Normothermia was
maintained using a homeothermic heat pad (Harvard Apparatus, Kent, UK). Heart rate and
hemoglobin saturation in oxygen were monitored using a rodent pulse oxymeter (Physiosuite,
Kent ScientificCorporation, Torrington, USA). At the end of the procedure (see below), sevo-
flurane was discontinued and the rats were allowed to recover for a fewminutes on the heat
pad (O2: 1.5 l.min-1) before transfer to an incubator (28±3 deg C) until full recovery of coordi-
nated motor function (10–15 min). The duration of anaesthesia was approximately 5 minutes
(no surgery) to 15 min (surgery, see below).
Table 1. Treatment groups in phase 1 of the study.
A. 1st Phase Treatment N Drug Route Dose [mg.kg-1] Volume [ml.kg-1]
1.1 6 NaCl 0.9% SC N/A 3
1.2 6 NaCl 0.9% IT N/A 0.2
1.3 6 Morphine SC 3 3
1.4 6 Morphine IT 0.2 0.2
doi:10.1371/journal.pone.0163909.t001
Table 2. Treatment groups in phase 2 of the study.
B. 2nd Phase Treatment N Surgery Drug Route Dose [mg.kg-1] Volume [ml.kg-1]
2.1 7 Sham NaCl 0.9% SC N/A 3
2.2 7 Laparotomy NaCl 0.9% IT N/A 0.2
2.3 7 Laparotomy Morphine SC 3 3
2.4 7 Laparotomy Morphine IT 0.2 0.2
doi:10.1371/journal.pone.0163909.t002
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Injections
Regardless of their allocated treatment groups, all rats had the abdomen and lumbosacral area
shaved at the start of the maintenance of anaesthesia. The shaved areas were cleaned with a
diluted solution of chlorhexidine. Rats allocated to treatments 1.1, 1.2, 2.1, 2.2 were injected
subcutaneously in the scruff with a sterile 25G needle and hypodermic syringe. Rats allocated
to treatments 1.3, 1.4, 2.3, 2.4 were positioned in sternal recumbencywith their pelvic limbs
brought under the abdomen as cranially as possible in order to arch the lumbosacral area. The
intrathecal injection was performed using aseptic techniques, using a 25G hypodermic needle
and an insulin syringe (0.5ml). The injection site was between the last lumbar vertebra and the
1st sacral vertebrae (L6-S1) (Fig 1). The injection was considered successful if one of the 2 fol-
lowing signs were noted: presence of CSF in the needle hub prior to injection and/or twitch of
the tail during the injection. If none of these signs were noted, or if bloodwas visible in the nee-
dle hub prior to injection, the needle was withdrawn and another sterile needle was used to
repeat the procedure. All intrathecal injections were successful at the 1st or 2nd attempt.
Fig 1. Intrathecal injection in rats: anatomical landmarks and site of injection. Cx: coccygeal vertebrae, L5: fifth lumbar
verterbrae, L6: sixth lumbar vertebrae, S: sacrum. $: injection site (L6-S1).
doi:10.1371/journal.pone.0163909.g001
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Surgery
Rats allocated to treatments 2.2, 2.3, 2.4 underwent a caudal laparotomy with bladder wall
injection immediately after the injections described above. The procedure is an adaptation
from a previously described technique to produce a clinically relevant model of abdominal sur-
gery [36,49]. Briefly, a caudal and midline laparotomy incision (1cm) was performed. The blad-
der was exposed and its wall injectedwith 0.1ml of sterile NaCl 0.9% (Braun, Melsungen,
Germany) with an insulin needle and syringe (Terumo, Inchinnan, UK). The abdominal mus-
cles were sutured with an interrupted pattern (4.0 Vicryl, Ethicon, Wokingham, UK) and the
skin with a subcuticular pattern of the same suture material.
Behaviour recording
A custommade filming cage (40 x 26 x 28 cm) was used for behavioural recording. The cage
did not contain any bedding, food or water. Three vertical sides, floor and ceiling were lined
with a matte black film (Fablon) to minimise sensory distraction and reflections.A high defini-
tion camera (Sony High DefinitionHandyCam model HDR-XR155, Sony, Japan) was posi-
tioned using a tripod to face the remaining clear Perspex side of the cage. The rats were placed
individually in the cage, allowed to acclimatize for 5 minutes and filmed for 10 minutes without
an observer being present in the filming area. The box was thoroughly cleaned after filming
each animal. Each rat was filmed on the day prior to the procedure (baseline = T0) as well as at
1, 2, 4, and 8h post-injection.
Phase 1 of the study. An operator blinded to the rats’ treatment scored each 10-minute
video clip using open-source software designed to score animal behaviour from video clips
(Cowlog) [50]. Behavioural scoring was performed using a validated rat ethogram [36,49,51].
The ethogram is summarised in Table 3. Duration and frequency for each of the defined behav-
iours were recorded. A Composite Pain Behaviour (CPB) score was calculated by summing the
frequency of the pain behaviours for each individual rat at each time-point. Pain behaviours
included in the CPB in this phase were: back arching, twitch and stagger/fall.
Phase 2 of the study. One treatment-blinded operator (KH) (blinded to time point and
treatment) was responsible for all behavioural assessments. Briefly, the video was played in real
time, and the operator scored the incidence of certain specific behaviours. Pain behaviours
included in the CPB score in this phase were: back arching, twitch, stagger/fall, and belly press-
ing. Behaviour scoring of 5 minute per rat, per time point was carried out.
Rat Grimace Scale
Following video recording for behavioural analysis, rats were placed in a photography box for a
period of 5 minutes and photographed using a high definition camera (Casio EX-ZR100, Casio
Computer Co., Ltd., Japan) by a treatment-blinded observer. The photography box consisted of
twomatte black walls and two clear Perspex walls (27cm x 19cm x 17cm). Rats were photo-
graphed on every occasion they directly faced the camera, apart fromwhen grooming in accor-
dance with the method describedby Sotocinal and colleagues [40]. The rats were then returned
to their home cages. A treatment-blinded observer recorded any unexpected event or complica-
tion related to picture acquisition. The box was thoroughly cleaned and dried after photogrpah-
ing each animal. All out-of-focus or out-of-frame images were manually deleted. The remaining
images were cropped, leaving only the face of the rat in view to prevent bias due to body posture
[41]. Using a random number generator, one image per rat, per time point was selected.Using
the random number generator again, the selected images were re-ordered and inserted into a cus-
tom designed excel file for scoring. Nine trained observerswho were blinded to the experimental
details, design and purpose of the study scored each photograph for the four facial action units
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(FAUs) comprising the RGS as describedby Sotocinal and colleagues [40]. For each image, the 4
individual FAUS: orbit tightening, nose / cheek flattening, ear changes and whisker change were
scored using a 3-point scale (0 = not present, 1 = moderately present, 2 = obviously present). The
nine scorers consisted of 5 veterinarians (including 2 with experience of working with rodents)
and 4 scientists with no experience of working with rodents.
All rats were euthanized using a rising concentration of inhaled C02 (filling rate: 20% of the
chamber volume per minute) following recording of the last set of data, 8h post-injection, in
accordance with current guidelines and legislation [4,52].
Statistical Analysis
All statistical analyses were conducted using SPSS (SPSS Inc. Chicago, USA). A sphericity test
was performed to verify the parametric nature of the data after which repeated measures
Table 3. Ethogram used for behavioural observations in phase 1. Adapted from references [36,49,51].
Behaviour Description
Pain Behaviours Back arching Vertical stretch as in felines upon waking, including both partial and full arches, while inactive or walking.
Twitch Transient involuntary muscular contraction of any body part. Usually occurs while inactive.
Stagger/ fall Rapid transition to crouch from high or low rear. Also, falling during grooming while crouched.
Belly Pressing Rubbing the laparotomy site purposefully across the floor of the cage
Writhe One or more contractions of the abdominal muscle on either side of the stationary or moving animal, lasting until
the abdomen relaxes.
Ambulatory
Behaviours
High rear Bipedal stance, fully erect posture
Down to partial Downward movement from high rear to partial rear
Partial rear Bipedal stance, low or half–erect posture
Down to floor Downward movement from either high rear, partial rear, jump or climb to quadrupedal contact with the cage floor
Walk Quadrupedal ambulatory movement
Inactive Still, no on–going activity
Jump Transient vertical projection of entire body, usually follows high rear
Climb Hind paws not in contact with the cage floor, usually follows high rear or precedes jump
Other Any behaviour not specified. See below.
Grooming
Behaviours
Groom head Grooming, licking or scratching head
Groom limbs Grooming, licking or scratching limbs
Groom
abdomen
Grooming, licking or scratching abdomen, includes paying attention to wound site or abdominal shaved area
Groom back Grooming, licking or scratching back, includes paying attention to lumbar shaved area
Groom tail Grooming, licking or scratching tail
Other Behaviours Investigate Vigorously sniff, explore, or inspect something. Recorded only when done in isolation (animal usually inactive or
between ambulatory behaviours). Usually investigate a cage item but can sniff the air.
Chew Bite or gnaw part of the cage. Usually cage walls but can include masticating a cage item such as a piece of
substrate
Eat Ingestion of an item
Stretch Horizontal elongation of body. Usually precedes and follows walking.
Shake Instantaneous shuddering lateral whole body movements
Lift hind leg Transient upward movement of one hind paw or hind leg so that it is no longer in contact with the floor
Squint Partial closure of eyes
Teeth chatter Vertical or lateral mouth/ jaw movements or teeth grinding in the absence of any obvious item to be chewed or
eaten
Dig Digging on cage floor, usually with forepaws. Usually follows investigate
Miscellaneous ‘other’ behaviours On each occasion ‘other’ was scored, a note was made of this behaviour that was being performed by the rat.
doi:10.1371/journal.pone.0163909.t003
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ANOVA with ‘time’ as a within subjects factor and ‘treatment’ as a between subjects factor
were performed. Pairwise comparisons were examined with post hoc analysis (Bonferroni).
Data from the 1st and 2nd phases of the study were analysed separately. Differences were con-
sidered significant if p<0.05.
The RGS (0–8) score was obtained by averaging the scores (0–2) obtained for each of the 4
action units (AU) for each analysed image. Time effects within treatments were assessed with a
Friedman’s test. Treatment effect at each time points were identified using a Kruskall-Wallis
test and further investigated with Mann-Whitney U Tests and Bonferroni corrections for mul-
tiple comparisons. Comparisons of equivalent treatments across study phases (i.e. treatments
1.1 vs. 2.1; 1.2 vs. 2.2; 1.3 vs. 2.3; 1.4 vs. 2.4) were also performed usingMann-Whitney U Tests
with adjusted Bonferroni corrections for multiple comparisons. Finally, the level of consistency
(reliability) between scorers was illustrated with Intraclass Correlation Coefficients (ICC) for
each action unit as well as for the total RGS score. In all cases, differences were considered sig-
nificant if p<0.05.
Power of the study
Retrospective assessment of the power of the study (2nd phase only) was performed using
GPower (SoftnewsNET SRL, Romania).
For the behavioural analysis (CPB), the power exceeded 0.8 with respect to differences
between time points and with respect to differences between the saline surgical group and both
morphine groups. The power with which to detect differences between the morphine groups
was approximately 0.4. Similar results were obtained for the RGS (within subjects, power>0.8;
within morphine groups: 0.33).
Results
Phase 1: treatments 1.1 to 1.4
Effect of morphine (SC and IT) on the behaviour of pain-free rats. There was no signifi-
cant treatment effect on the behaviour of rats. Neither morphine administered SC or IT, or
NaCl significantly affected the frequency and duration of behaviours identified in the rat
ethogram
Time had a significant effect on some of the behaviours across all treatments (1.1 to 1.4), as
illustrated in Fig 2. As such, the frequency of high rears significantly decreases (p<0.001), the
duration of walking decreased (p<0.001), the duration of climbing behaviours were signifi-
cantly higher at baseline compared to other time points (p = 0.03). Lastly, the duration of inac-
tivity increased over time with duration of inactivity being significantly lower at baseline
compared to other time points (p<0.001). There was no significant effect of time on any of the
other analysed behaviours. No pain specific behaviours were detected.
Effect of morphine (SC and IT) on Rat Grimace Scale (RGS) score in pain-free rats.
Average AU RGS results are documented in Fig 3 and Table 4.
Average AU RGS scores were significantly different across treatments at baseline, 1 and 4h
post injection. At 1h post-injection, rats receiving intrathecal NaCl had a significantly lower
RGS score than rats having receivedNaCl subcutaneously (p = 0.002). At 4h post-injection,
total RGS was significantly lower in rats allocated to the NaCl IT group compared to: NaCl SC
(p<0.001) and the morphine groups (morphine SC: p = 0.006; morphine IT: p<0.001) com-
pared to their respective control groups.
Average AU RGS score also significantly increased over time in pain-free rats for all treat-
ments except morphine intrathecally (Fig 3 and Table 4).
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Phase 2: treatments 2.1 to 2.4
Analgesic properties of intrathecalmorphine in rats subjected to acute surgical pain.
The surgical model used in the present study (caudal laparotomy with bladder wall injection)
resulted in the presence of previously validated, specific pain behaviours such as writhing, fall/
stagger, twitches, and belly pressing. The incidence of back arching was very low and was there-
fore removed from the analysis. The composite pain behaviour (CPB) score was therefore
obtained using the mean frequencies of the following behaviours: writhing, fall/stagger, belly
pressing and twitches (Fig 4). CPB score was very low and not significantly different between
treatment groups at baseline. Rats allocated to undergo surgery and receive an intrathecal injec-
tion of NaCl showed had a significantly higher CPB score than other rats allocated to the sham
group at all postoperative time points (Table 5). The peak of CPB was observed at 2h post
surgery.
Morphine, administered subcutaneously or intrathecally, resulted in significantly lower
CPB scores compared to control rats (NaCl IT, surgery) at all time points. CPB scores in mor-
phine-treated rats (either SC or IT) were not significantly different to CPB scores in the sham
surgery group. There was no significant difference in the CPB score of rats undergoing surgery
Fig 2. Representation of mean duration or frequency of the most commonly observed behaviours in pain-free
rats (1st phase study) ± 2 standard error to the mean. N = 24, pooled data for treatment groups 1.1 to 1.4. There
was no significant treatment effect between groups. A: significant decrease of rearing frequency over time (p<0.001);
B: significant decrease of time spent walking over time (p<0.001); C: Time spent climbing is significantly higher at
baseline than at any further time point (P = 0.036); D: significant increase of the time spent inactive (p = 0.001).
doi:10.1371/journal.pone.0163909.g002
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and receivingmorphine either subcutaneously or intrathecally, at any time point. See Table 5
for the full list of significant differences between treatments at all time points.
Average AU RGS scores for rats undergoing surgery and receivingNaCl IT significantly
changed over time: average AU scores were significantly lower at baseline compared to 8h post
laparotomy (p<0.01), but not at other time points. Similar results were obtained for rats under-
going sham surgery. Average AU scores for rats undergoing surgery and receivingmorphine
remained similar over time if the drug was administered subcutaneously, but were higher 8h
post surgery if morphine was injected IT (p<0.001). Detailed results are displayed in Fig 5 and
Table 6.
Fig 3. Average Action Unit RGS scores for treatments 1.1 (NaCl SC); 1.2 (NaCl IT); 1.3 (Morphine SC) and 1.4 (morphine IT) over time. N = 24 (Solid
line = median, box = 1st and 3rd quartiles, whiskers = minimum and maximum, $, = Outliers). AU: Action Unit. P-values are indicated where differences are
significant.
doi:10.1371/journal.pone.0163909.g003
Table 4. Within-subjects comparison between post treatment time-points with baseline with associ-
ated p-values for differences where significance was found (phase 1 of the study). Differences are sig-
nificant if p<0.05. AU: Action Unit; SC: Subcutaneous; IT: Intrathecal; ND: No significant difference.
Average AU Scores- NaCl SC
Time point 1h 2h 4h 8h
Baseline <0.001 0.002 0.003 0.001
Average AU Scores–NaCl IT
Time point 1h 2h 4h 8h
Baseline ND ND 0.001 ND
Average AU Scores- Morphine SC
Time point 1h 2h 4h 8h
Baseline 0.007 0.007 ND 0.007
doi:10.1371/journal.pone.0163909.t004
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Morphine-treated rats (SC and IT) undergoing surgery, displayed significantly lower total
RGS scores than control rats (NaCl IT) 1h post-surgery (p<0.001, p = 0.001 respectively). Sim-
ilar pattern of significant differences were identified 8h post-surgery (p = 0.001–0.002). RGS
scores were not significantly different between the morphine groups at 1, 2, and 8h postopera-
tively. RGS scores were not significantly different across treatments 2h post laparotomy. At 4h
post laparotomy; RGS scores were not significantly different between rats allocated to the sham
surgery groups and those allocated to the surgical groups and intrathecal NaCl.
Average AU RGS scores across treatments were significantly different at baseline between
rats allocated to receive morphine SC and (p = 0.01). No other significant differences were
noted between groups at baseline.
Reliability of RGS scoring
The reliability of both the individual AUs and the overall RGS scoring across all 9 scorers was
high with intraclass correlation (ICC) values for the individual AUs ranging from 0.69 (nose/
cheek flattening) to 0.94 (orbital tightening) and a value of 0.91 for the overall RGS score
(P<0.0.001 for all comparisons) (Table 7).
Discussion
This novel study demonstrates the effects of morphine injected intrathecally via direct lumbar
puncture in pain-free rats and in a model of acute surgical pain. In addition, this study repre-
sents the first use of the Rat Grimace Scale to assess the analgesic properties of IT morphine.
Fig 4. Mean frequencies for Composite Pain Behaviour (CPB) scores across treatments and time points. Data presented ± 2 standard error of the
mean. N = 28. Significant differences (*) are explained in the text and Table 5.
doi:10.1371/journal.pone.0163909.g004
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Effects of morphine SC and IT on the behaviour and facial expression of
pain-free rats
The 1st phase of the study was designed to determine whethermorphine, administered SC or
IT, influenced behaviour or rat grimace score (RGS) of pain-free rats. At the doses chosen in
this study morphine, injected subcutaneously or intrathecally, did not affect the frequency and
duration of behaviours used in a validated rat ethogram [36]. All changes in behavioural scope
and pattern in the second phase of the study, in particular behaviours included in the CPB
score, can therefore be attributed to the acute surgical pain caused by caudal laparotomy and
Fig 5. Average Action Unit RGS scores for treatments 2.1 (NaCl SC + sham surgery); 2.2 (NaCl IT + surgery); 2.3 (morphine SC + surgery) and 2.4
(morphine IT + surgery) over time (Solid line = median, box = 1st and 3rd quartiles, whiskers = minimum and maximum, $, = Outliers). N = 28. P-
values are indicated where differences are significant (<0.05).
doi:10.1371/journal.pone.0163909.g005
Table 6. Within-subjects comparison between post treatment time-points with baseline with associ-
ated p-values for differences where significance was found (Phase 2 of the study). Differences are sig-
nificant if p<0.05. AU: Action Unit; SC: Subcutaneous; IT: Intrathecal; ND: No significant difference.
Average AU Scores- NaCl SC, Sham
Time Point 1h 2h 4h 8h
Baseline ND ND ND 0.010
Average AU Scores–NaCl IT, Surgery
Time Point 1h 2h 4h 8h
Baseline ND ND ND <0.001
Average AU Scores- Morphine IT, Surgery
Time Point 1h 2h 4h 8h
Baseline ND ND <0.001 <0.001
doi:10.1371/journal.pone.0163909.t006
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bladder injection. This finding is contrary to the common belief that opioids alter the behav-
iour of pain-free rodents [38]. Morphine as well as other opioids do influence the behaviours of
pain-free rats, but this has generally been reported when the doses used are much greater than
those recommended for clinical use in rats [14,38], or when opioids are administered repeat-
edly for example in models of opioid tolerance [53,54]. The activity of all rats decreased over
time, regardless of the drug received (NaCl or morphine). This reflects either insufficient habit-
uation to the recording box (5 min) prior to the recording (novelty effect) during the early time
points; or habituation of the rats, and possible boredom after several recordings in quick suc-
cession (a total of 5, 10 min long, behaviour recording sessions) [55,56].
The effect of morphine and the route of administration on pain-free rats were not easily
interpreted using RGS. Average AU scores increased over time for all pain-free treatment
groups, with the exception of intrathecal morphine. Each of the behavioural recording session
was followed by another 10 min long session in a smaller Plexiglas box for RGS scoring.Whilst
activity was not recorded in the RGS box, it was observed that the rats were also more inactive
over time during the RGS sessions. Several rats were seen to remain immobile for a large part
of the RGS session, and appeared disinterested by their surroundings. Such observations seem
to correlate with the overall activity patterns (i.e. inactivity and walk). In the authors’ experi-
ence, it would be reasonable to assume that inactive rats placed in a familiar environment
could intermittently show signs of drowsiness. Given that orbital tightening is a natural conse-
quence of drowsiness, then an increase in RGS score over time within all treatment groups
could have been expected.One might argue that the sedative properties of morphine [14,57,58]
could have further accentuated this expected effect, as sedation has already been shown to
increase grimace scale scores [59]. While pain-free rats having receivedNaCl SC had a signifi-
cantly lower RGS at baseline than at other time points; this pattern was not repeated in the
NaCl IT group.
Interestingly, RGS scores for pain-free rats receivingmorphine IT did not change signifi-
cantly over time, despite the same decrease in activity shown by control rats. Intrathecal mor-
phine may therefore have an effect on facial expression of pain-free rats. Typically, pain-free
rats receiving IT morphine displayed seemingly wider and slightly more protuberant eyes, than
in control rats. This facial appearance of pain-free rats receivingmorphine was documented as
exophthalmos by some of the RGS treatment-blinded scorers. Morphine is known to cause
mydriasis and exophthalmos in pain-free rats [60–62], but this effect was not analysed for sig-
nificance in our study. Exophthalmos, which is not taken into account by the RGS, might have
counteracted any possible orbital tightening from somnolence in the later time points.
Lastly, pain-free rats receivingmorphine SC had a significantly higher RGS score 1, 2 and
8h post injection. This could be explained by the sedative properties of morphine [14,57,58]
causing some additional degree of orbital tightening. However, if any sedation occurred, this
was not reflected by behaviour changes 1h post-injection.
Table 7. Inter-rater reliability for the Rat Grimace Scale (2nd phase of the study).
ICC (average) 95% CI P
Overall RGS 0.913 0.893–0.931 P <0.001
Orbital tightening 0.940 0.929–0.951 P <0.001
Ear positioning 0.880 0.857–0.901 P <0.001
Nose and cheek flattening 0.688 0.626–0.743 P <0.001
Whisker change 0.796 0.750–0.837 P <0.001
Intraclass correlation coefficient (ICC) calculated for multiple (average) raters (n = 9).
doi:10.1371/journal.pone.0163909.t007
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Analgesic properties of intrathecal morphine for acute surgical pain
The pain caused by the model chosen for this study (caudal laparotomy with bladder wall injec-
tion) has been well documented using composite pain behaviour scoring [36,63]. This surgical
procedure remains widely used in orthotopic models of bladder cancers in our institution and
elsewhere [64,65]. The presence of detectable pain was confirmed by the significant increase in
composite pain behaviours in the positive control group up to the last recorded time point, 8h
post surgery. This is in line with previously reported pain mediated behavioural alteration,
where laparotomy was associated with an increase of pain specific pain behaviour for up to
6.5h [51]; as well as non-specific behavioural alteration for up to 24h [66].
Morphine administered intrathecally via direct lumbosacral puncture significantly attenu-
ated composite pain behaviours (1 and 4h postoperatively) and rat grimace scores (1 and 8h
post surgery), and therefore seems to alleviate acute postsurgical pain caused by caudal laparot-
omy. Morphine IT was mostly indistinguishable from subcutaneous administration based on
RGS scoring, but analysis of the composite pain behavior score suggested that SC morphine
might provide uninterrupted analgesia for up to 8h.
The duration of action of morphine administered subcutaneously (8h) was longer than
expected since morphine SC is usually considered to provide effective post-operative analgesia
for no more than 2-4h [14,67,68], with a peak of analgesic and anti-hyperalgesic activity 45–60
min post administration [67]. Morphine administered intrathecally is expected to provide long
lasting analgesia in people [69] and animals [70–72]. While neuraxial morphine was shown to
have a duration of action of 21h in primates [70], and up to 24h in dogs and cats [71,72], intra-
thecal morphine has been associated with markedly shorter duration of action in rats. Most
studies undertaken in rats reported a duration of action of approximately 120 min
[32,33,73,74]. Results obtained in the present study suggest that intrathecal morphine in rats,
might have a longer duration of action. Three key elements of our study design could explain
this difference from previous studies. Firstly, the present study documents analgesic properties
of morphine in the context of acute surgical pain, using specific pain behaviours validated for
post-laparotomy pain in rats. Most other studies assessed the anti-nociceptive properties of
morphine using various nociceptive tests (e.g. Von Frey, Hargreaves). Secondly, in our study,
in order to assess the practicality of intrathecal administration of post-operative pain manage-
ment, morphine was administered without prior surgical implantation of a spinal catheter. A
spinal catheter is widely used in pharmacological or toxicological studies to facilitate multiple
injections of a substance. The presence of the catheter may be associated with chronic inflam-
matory pain, alteration of rats’ behaviours, and intrinsic variation in the pharmacological prop-
erties of some molecules, including morphine [33,75]. Thirdly, the dose used in the present
study (0.2 mg.kg-1, IT, i.e. average 54μg per rat) was higher than doses used in most anti-noci-
ceptive studies (e.g. 0.16 to 10 μg per rat) [28,29,32,33].When selectedmorphine doses were
higher, anti-hyperalgesic properties of intrathecal morphine was anecdotally documented to
last for up to 4h [76].
The dose chosen was based on pilot studies conducted in our laboratory (unpublished data)
and represented the highest dose that could be administered intrathecally without producing
clinical and behavioural side effects.We ensured that the total amount remained below 150μg
per rat, the intrathecal dose reported to trigger hyperalgesia in rats [77]. A total dose of 0.2 mg.
kg-1 in rats is also higher than intrathecal doses commonly used in human analgesia
[25,27,78,79], even after applying allometric scaling [80]. Further studies would be required to
identify the lowest intrathecal dose required to inhibit composite pain behaviours in rats
undergoing laparotomies and other surgical procedures involving the abdomen and the pelvic
limbs. Lastly, the effects of a low morphine dose (54μg or below) administered intrathecally on
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the immune system and cancer models is unknown to date, but would be expected to be lower
than systemic doses previously investigated [22,23].
Relevance of the rat grimace scale for assessing pain in opioid
medicated rats
A range of different approaches have been developed to assess the degree of pain experienced
by rats undergoing surgical and other traumatic pain, with the view of refining the procedures
and/or improving the relevance of translational studies. Beyond nonspecific and retrospective
methods (such as weight loss, biochemical stress markers etc.), two prospective pain assess-
ment methods are currently most relied upon. Behaviour-based assessments of pain have been
developed for both rats and mice following surgery and other traumatic procedures, and use
either the appearance of abnormal behaviours, or the change in the frequency of normal behav-
iour patterns to score pain [11,49,51,81]. There remain a number of limitations to using behav-
iour to assess pain in animals, such as possible confounding factor of opioid analgesic on the
behaviour of pain-free animals [51] and the specific behavioural responses to painful stimuli
varyingmarkedly depending on the nature of the surgical procedure (abdominal-basedor
other) [11,49,51,81]. The use of facial expressions to assess pain [40] was suggested to over-
come some of the above difficulties.Variation of facial expression during painful events was
codified as the Rat Grimace Scale (RGS), validated for the assessment of acute surgical and
nociceptive pain [40,43,82], and used to assess the efficacy of commonly used analgesics in rats
[45]. Amongst the proposed advantages supporting the use of RGS was the lack of a confound-
ing effect of opioids on the facial expression of pain-free animals. The present study suggests
that opioids may have an effect on facial expression of pain-free rats (overall decrease of RGS
scores over time) caused by a degree of opioid-mediated exophthalmos, but no behavioural
effect over time. These findings would benefit from further investigation.
In rats subjected to acute surgical pain, unexpected findings have weakened our interpreta-
tion from RGS results. RGS scores in pain free and opioid free rats were expected to be lower
than were observed in this study [40] and similar across treatment groups. Importantly, signifi-
cant differences were detected amongst treatment groups at baseline during both phases of the
study. This major inconsistency existed despite overall excellent inter-scorer reliability of the
scoringmethod (ICC 0.913). Three factors either in isolation or combination may have con-
tributed to such findings. Firstly, in mice, baselinemouse grimace scale scores were shown to
differ depending on the strain, sex, and methods used for the scoring of facial action units (ret-
rospective vs. prospective scoring) [83]. While variation of baseline scores across strains in
Wistar rats, or the impact of retrospective RGS scoring on still images are yet to be documented
in a specific study, significant differences amongst baseline RGS scores between treatment
groups were unexpected. Rats (strain, age, sex, age), operators, time of the days and methodol-
ogy used was similar between both study phases. However, this requires further study as the
above finding is based on a single study in 6 mice. A second reason that potentially contributed
to the differences in RGS scores at baseline between rats could, more simply, be a cohort effect.
All rats were bred by the same supplier, were of a similar age, strain, and received equivalent
husbandry in our laboratory. In addition, group housing and random allocation of each rat to
his treatment group would be expected to minimize the likelihood of such cohort effect. None-
theless, the statistical analysis used for this study compensated for any possible cohort effect
since using a within-subjects design accounts for the variation between individuals when com-
paring across time points. Thirdly, a relatively short yet consistent habitation periodwas used
in these studies (5 min), and therefore it is possible that the novel nature of the box used con-
tributed to the variability of facial expressions of the rats, possibly causing inadvertent false
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positive scoring at baseline that were reduced with repeated exposures. This effect has however
not been noted in other studies using grimace scales when similar habitation times [59] or dif-
ferent [82] habituation times were used.
While the overall power of our studies was acceptable (>0.8), the lower power observed
between the morphine comparisons should be taken into account when interpreting the results
of this pilot study. These comparisons bear further investigation in a future study. This pilot
study will provide more accurate information for the sample size determination of future stud-
ies than was available when this pilot study was undertaken.
Only female rats were used in this study. Pain perception and analgesic properties of opioid
are influenced by gender in rats. Briefly, female rodents are more sensitive than males to nox-
ious stimuli and have lower levels of stress-induced analgesia, whereas male rodents generally
have stronger analgesic responses to mu-opioid receptor agonists than females [84,85]. In spite
of this, gender was not found to significantly influence specific pain behaviours in similar surgi-
cal models of pain in rats [49], and no sex-differenceswere reported in the original RGS paper
[40]. We chose to use single sex female groups and minimise the number of rats involved in
this study. Further studies would be required to characterise gender-based difference in the
analgesic properties of intrathecal morphine.
Conclusion
Findings from the present study suggest that administration of intrathecal morphine by percu-
taneous injectionmay represent an effectiveway of providing long lasting pain relief in rodents
subjected to caudal laparotomy and bladder wall injection. Intrathecal morphine (0.2 mg.kg-1)
may provide comparable analgesia to the subcutaneous route (3 mg.kg-1) using less that a 10th
of the dose required for subcutaneous administration. As a result, the intrathecal route of
administrationmay reduce concerns related to the non-specific effects of opioids when these
agents are used to alleviate pain in rodents used in a range of different areas of biomedical
research. Further studies would be required to better characterize the effects of such reduced
morphine dose on individual experimental outcomes.
While the RGS may have advantages for the assessment of pain in rats compared to scoring
of composite pain behaviours, morphine may impact facial expression of pain-free rats and
influence use of the RGS in opioid medicated rats. The variation in detection of analgesic
effects between the RGS and the CPB score support the use of both techniques, as complemen-
tarymeasures of the behavioural changes induced both by analgesics and post-surgical pain.
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